Genelux GNLX
NASDAQ GNLX
$2.07 -0.43 (-17.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Interest Expenses (2022 - 2023)

Updated

Genelux (GNLX) recorded Interest Expenses of -$131,000 in Q4 2023.

Analysis

Genelux (GNLX) Interest Expenses (2022 - 2023) Analysis & Trends

For FY2023, Genelux reported Interest Expenses of $36,000.

  • Per Business Quant, the preceding three quarters came in at $131,000 (Q3 2023), -$107,000 (Q2 2023) and $143,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Genelux 91.17 Mn 29.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -131,000.00
Sep 30, 2023 131,000.00
Jun 30, 2023 -107,000.00
Mar 31, 2023 143,000.00
Mar 31, 2022 288,000.00
API Access

Genelux Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=GNLX&period=max&api_key=YOUR_API_KEY